This register shows current declarations of interest made by our:
- non-executive directors
- executive team members
- senior leaders.
We publish it as part of our commitment to transparency and openness.
We keep a record of previously declared interests for 2 years. Contact us to request information about previous interests.
Our declaration of interests policy (Word) explains what we mean by 'interests' and:
- when they must be declared
- how they are recorded
- how conflicts of interest are managed.
|Sharmila Nebhrajani OBE (board chairman)||Chairman, Sovereign Grant Audit Committee. (non-remunerated)
Non-executive director, Lord Chamberlain's Committee. (remunerated)
Non-executive director, Coutts & Co. (remunerated)
Trustee, Glyndebourne Productions Ltd. (non-remunerated)
Non-executive director, ITV plc. (remunerated)
Non-executive director, Severn Trent Water plc. (remunerated)
Non-executive director, National Savings & Investment. (remunerated)
Non-executive director, Halma plc. (remunerated)
|Dr Mark Chakravarty (non-executive director)||Co-owner and company director, Squarecircle Consulting GmbH. (remunerated)
Spouse is owner and company director, Squarecircle Consulting GmbH. (remunerated)
Adviser and investor, Quantified Communications Inc, shares and convertible debt. (remunerated)
Consulting Executive, Corporate Visions Inc. Communications Training. (remunerated)
Novartis & Alcon shares and options which are either blocked or managed under a blind mandate.
|Jackie Fielding (non-executive director)||Non-executive director, Sequana Medical. (remunerated)
Governor, South Tyneside and Sunderland NHS Foundation Trust. (non-remunerated)
Chair, Northumbria Primary Care Ltd. (remunerated)
Adviser, HealthComms Consulting. (remunerated)
Non-executive director, 3D Lifeprints. (remunerated)
|Professor Gary Ford CBE (non-executive director)||CSL Behring Consultancy advice for stroke trial design. (remunerated)
Chair Trial Steering Committee NIHR funded Pharyngeal Electrical stimulation for Acute Stroke dysphagia Trial (PhEAST). (non-remunerated)
Board member, Accelerated Access Collaborative. (non-remunerated)
Chair, Pfizer/Bristol Myers Squibb independent atrial fibrillation detection improvement grants – not product related. (non-remunerated)
Chair, Academic Health Science Network. (non-remunerated)
Trustee, Health Services Research UK. (non-remunerated)
Director, Cogentis and Accelerare companies, support activities of the Oxford Academic Health Science Network. (non-remunerated)
Trustee, Picker Institute. (non-remunerated)
Professor of stroke medicine, Green Templeton College, Oxford University, Governing Body Fellow. (non-remunerated)
Consultant physician, Oxford University Hospitals NHS Foundation Trust. (remunerated)
Chief executive officer, Oxford Academic Health Science Network. (remunerated)
Strategy board member, National Institute for Health Research. (non-remunerated)
Lecture on ‘Neuroprotection in acute ischaemic stroke. Trials of Edaravone’ at Ukraine Conference – ‘Third Interdisciplinary College of Neurological Diseases’. (renumerated - speaker honorarium paid to a Ukrainian Humanitarian Aid Charity)
|Dame Elaine Inglesby-Burke DBE (non-executive director)||Interim chief nursing officer at Liverpool University Hospitals NHS Foundation Trust. (remunerated)
Senior lead (COVID-19 support), NHS England and NHS Improvement North West. (remunerated)
Board member, AQuA (Advancing Quality Alliance). (non-remunerated)
Trustee at Willowbrook Hospice, Merseyside. (non-remunerated)
|Alina Lourie (non-executive director)||Board member, Agrimetrics. (remunerated)
Member, Knowledges and Services Board, and special advisor, Institute of Engineering and Technology. (remunerated)
Board member, Manchester University Press. (non-remunerated)
Vice chair of the Board and chair of Business Development Committee, Thrive. (non-remunerated)
|Professor Bee Wee CBE (non-executive director)||Honorary Professor in Palliative Medicine, Sichuan University, China. (non-remunerated)
Visiting professor, Lewis-Manning Hospice. (non-remunerated)
Co-opted trustee to the Faculty of Medical Leadership and Management Board. (non-remunerated)
Donation governor, Christ's Hospital. (non-remunerated)
National clinical director for end of life care, NHS England and NHS Improvement. (remunerated)
Official fellow, Harris Manchester College, University of Oxford. (remunerated)
Consultant and senior lecturer in palliative medicine, Oxford University Hospitals NHS Foundation Trust. (remunerated)
|Dr Justin Whatling (non-executive director)||Managing director, Global Health and Life Sciences at Palantir Technologies. (remunerated)
Member of Academy of Computing Board, BCS The Chartered Institute of IT. Representing BCS on the BMJ Health & Care Informatics Journal’s Management Committee. (non-remunerated)
Audit and finance committee member, Faculty of Clinical Informatics. (non-remunerated)
Member of CW+ Innovation Advisory Group. Led by Chelsea and Westminster Hospital NHS Foundation Trust and its offical charity CW+. (non-remunerated)
Visiting professor in health informatics, Centre for Health Informatics and Multiprofessional Education at University College London. (non-remunerated)
Executive team members
|Executive team member||Interests|
|Samantha Roberts (chief executive)||Share options in Legal and General Plc. (non-remunerated)|
|Meindert Boysen (deputy chief executive and director of the Centre for Health Technology Evaluation)||Member, International Advisory Panel for the Agency for Care Effectiveness (ACE), Singapore. (remunerated - paid to NICE)|
|Mark Chapman (interim director medical technology)||Sister is Corporate Affairs and Governance Manager, Greater Manchester Integrated Care Board.
Spouse is Service Manager, Respiratory & Sleep Physiology, Blackpool Teaching Hospital NHS Foundation Trust.
Shareholding in Medtronic PLC (<0.0001 %).
|Dr Paul Chrisp (director of the Centre for Guidelines)||Member, external advisory board for the Plymouth Institute of Health and Care Research (PIHR). (non-remunerated)
Spouse works for Fishawack Health which offers medical communications and consulting services to a range of pharmaceutical companies.
|Nicole Gee (chief people officer)||Owner of Geenius Ltd. (non-remunerated at present)|
|Jane Gizbert (director of communications)||No registered interests.|
|Dr Felix Greaves (director of science, evidence and analytics)||Visiting honorary senior fellow at MRC Epidemiology Unit, Cambridge University. (non-remunerated)
Adviser at SameYou (a brain injury charity). (non-remunerated)
Senior clinical lecturer at the School of Public Health, Imperial College London. (remunerated)
Director of MedicineAfrica Ltd. (non-remunerated)
|Jennifer Howells (director of finance, strategy and transformation)||No registered interests.|
|Judith Richardson (acting director of health and social care)||Mentor for supported return to training (SuppoRTT) in the North West (remunerated), and North West School SuppoRTT Champion. (remunerated - paid to NICE)
Faculty of Public Health, Part B (OSPHE) examiner. (non-remunerated)
Educational supervisor for public health training. (non-remunerated)
|Alexia Tonnel (director of evidence resources)||No registered interests.|
The following interests have been declared by staff above salary grade 8d on the Agenda for Change or the equivalent salary on medical and dental terms and conditions.
|Gail Allsopp (interim chief medical officer)||Clinical lead for clinical policy, Royal College of General Practitioners (RCGP). (remunerated)
Board member, Faculty Vale of Trent (RCGP). (non-remunerated)
Clinical associate professor in primary care, University of Nottingham. (non-remunerated)
Trustee (volunteer), Rainbows Children’s Hospice. (non-remunerated)
General practitioner, Derbyshire Community Health Services. (remunerated)
|Nick Baillie (acting programme director, Health and Social Care Directorate)||Chair, International Network for Social Intervention Assessment.|
|Sara Bate (associate director, medicines education)||Clinical engagement lead, Royal College of Physicians as. Seconded until September 2021.|
|Nigel Beasley (adviser, fellows and scholars programmes)||Employed by Sheffield Teaching Hospitals NHS Trust.
Associate medical director for cancer services, Sheffield NHS Trust.
Member, NICE Indicators Advisory Committee.
Co-director Stanage Brewery Ltd.
|Jacoline Bouvy (technical director)||Editorial board member, Applied Health Economics and Health Policy (a Springer Journal).
Scientific advisory board member, IMI TransBioLine project.
|Christine Carson (programme director)||Trustee on the Board of Discovery, Dimensions Somerset SEV, supporting people with learning disabilities, autism, challenging behaviour and complex needs.|
|Anne Coppel (associate director, field team and sector lead||Registered pharmacist - General Pharmaceutical Council.|
|Nick Crabb (programme director, scientific affairs )||Member of the HTAi Global Policy Forum Organising Committee.|
|Kevin Harris (programme director and clinical advisor)||Associate dean for clinical affairs, University of Leicester (substantive employer).
Non-executive director, Leicestershire Partnership Trust.
Honorary consultant nephrologist, University Hospitals of Leicester.
Censor, Royal College of Physicians.
|Jeanette Kusel (director, nice scientific advice)||Partner is finance manager at a medical research company.
Sits on Business Development Committee of HTAi.
|Carole Longson (life sciences adviser)||Honorary professor of health technology assessment, University of Manchester.
Trustee, Peter Sowerby Foundation.
Reviewer, European Commission Horizon 2020 research projects (remunerated).
Non-executive director, Medicines Discovery Catapult, Innovate UK (remunerated).
Member, University of Manchester Biomedical Research Centre/Health Innovation Manchester Industrial Advisory Board.
Chief scientific officer, Association of the British Pharmaceutical Industry.
Independent advisor on a project related to UK medicines pricing, Office of Health Economics.
Independent strategic advisor, PharmaCCX.
Independent strategic advisor, NDA.
Independent scientific advisor, AESARA, on projects related to evidence generation plans for technologies in clinical development.
Independent scientific advisor, FFI Ventures GmBH, on projects related to evidence generation plans for technologies in clinical development.
Independent scientific advisor, Compass Pathways, on projects related to evidence generation plans for technologies in clinical development.
|Danielle Mason (associate director, brand and marketing communications)||Spouse is employed by Veeva Systems, a company that provides cloud-based software services to the life sciences industry.|
|Mark Minchin (associate director, quality)||Close family member (brother) is ‘Head of Technical and Commercial’ in the UK for an international care home operator.|
|Angela Parkin (associate director, medicines evidence and advice)||Daughter is employed by Department of Health and Social care but currently works for NHS X as a digital and tech policy officer.|
|Pilar Pinilla-Dominguez (principal scientific adviser, nice international)||Member of the Board of Directors of the Spanish Health Economics Association.|
|Hannah Patrick (consultant clinical advisor)||Haematologist, Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust.
Spouse and daughter work at Kings College Hospital, London.
|John Powell (consultant clinical adviser)||Part-time role for the University of Oxford as Senior Clinical Researcher and Associate.
Professor in the Nuffield Department of Primary Care Health Sciences.
Sessional work for NIHR as Editor-in-Chief of the NIHR HTA and EME monograph series and chair of the NIHR HTA and EME editorial board.
Honorary consultant contract with Public Health England.
Honorary consultant contract with Oxford Health NHS Foundation Trust.
Principal investigator on research studies. Department in Oxford receives external grant funding from grant awarding bodies. As PI, received research funding within the last 12 months from:
NIHR Health Services Delivery Research programme - Evaluating the NHS App in England.
NIHR HSDR. Co-PI. £540k. (2020-2022).
NIHR Oxford ARC - theme lead for Applied Digital Health in the NIHR-funded Oxford and Thames Valley Applied Research Collaboration (ARC). Approximately £1M funding for 2019-2024.
Occasional consultancy work in a personal capacity to advise on the medical content of television programmes. Currently advising Stone City Films on a very occasional basis about a proposal for a programme about medical ethics.
Spouse is employed (salaried) as a clinical psychologist by Oxford Health NHS Foundation Trust.
|Eric Power (programme director, medicines)||Registered with General Pharmaceutical Council.
Member, Royal Pharmaceutical Society.
Spouse employed in primary care team at NHS England.
|Koonal Shah (associate director)||Member, EuroQol Group (developers of the EQ-5D family of instruments). Since 2018 served on the EuroQol Executive Committee (an elected position; term expires in September 2021).
Honorary research fellow, School of Health and Related Research, University of Sheffield.
|Rebecca Smith (interim associate director, external communications)||Spouse works as picture editor at the Mail on Sunday|
|Sanjay Tanday (associate director, strategic communications)||Wife works for Cystic Fibrosis Trust.|
|Nichole Taske (associate director, methods and economics)||Private landlord.
Member of the QinetiQ Ethics Committee (QEC).
Board trustee of Breast Cancer UK (BCUK) and member of BCUK’s Independent Scientific Review Panel.
Volunteer Member of the Cochrane Scientific Committee.
|Jonathan Underhill (medicines consultant clinical adviser)||Spouse is managing director of Kayhill Consulting, a healthcare consultancy.
Member of the Scientific Committee of the European Association of Hospital Pharmacists (EAHP). This committee oversees the education programme for the EAHP, including their annual congress.
Honorary lectureship at Keele University School of Pharmacy.
Accredited COVID vaccinator.
|Sheela Upadhyaya (associate director, highly specialised technologies)||Working with FIPRA to facilitate a workshop to explore the OMP Regulation.
Working with RareiTi to build a technology enabled, data driven early access programme model in rare diseases.
AACS relationship & delivery lead.
Trustee, My Name is Doddie foundation.
Career mentorship for a team member at Costello Medical, interested in rare diseases.
Working with Costello Medical to deliver strategic support for non HTA market access activities.